Cohort selection with privacy protection

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The 23Andme, Inc. patent solves the following problem:

Now, clinical target specific genetic factors in human subjects research is often made to attract candidates who have a certain genetic condition through special pools (eg, patient groups), screening for particular genotypes studied, and the selection of members based on screening results. The selection process tends to be difficult for several reasons. First, a large number of candidates often need to recruit. To help these people, to make them interested in studying, and getting them to sign on to be expensive and time consuming. Second, all the candidates have to be screened to determine if they have a specific genetic condition, which is an expensive and laborious process. For study of rare genetic conditions in particular, many iterations will be needed to achieve a significant population study.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 9405818 B2 deals with Cohort selection with privacy protection.
Assembling a band include: receiving the genetic nature of information concerning a desired genetic traits; the use of genetic traits to seek information in a data store containing information previously genotyped individuals to take a group of candidates with the desired genetic traits; and gathering battalion based at least in part the group of candidates.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Polymorphisms associated with Parkinson’s disease

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The 23Andme, Inc. patent solves the following problem:

Parkinson's disease (PD) is a progressive degenerative disease of the central nervous system (CNS). PD is characterized by muscle rigidity, tremor, a slow physical movement (bradykinesia), impaired balance and coordination, and, in advanced stages, a loss of physical movement (akinesia). Over one million Americans suffer from Parkinson's disease, with prevalence of approximately 1 in 272 or 0.37% in the United States (US Census Bureau, Population Estimates, 2004).

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 8187811 B2 deals with Polymorphisms associated with Parkinson’s disease.
invention provides human polymorphisms associated with Parkinson's disease (PD). Also disclosed are compositions and methods for use in diagnostics, prognostics, prevention, treatment and / or study in PD.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.